Central Nervous System Stimulants
Research News and Information

Saturday, November 21, 2009

Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.

30 Oct 2009 We tested the hypothesis that increased dopaminergic sensitivity induced by olfactory bulbectomy is mediated by dysregulation of endocannabinoid signaling. Bilateral olfactory bulbectomy induces behavioral and neurobiological symptomatology related ... Read more...

Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.

21 Oct 2009 TAARs (trace amine-associated receptors) are G-protein-coupled receptors that respond to low abundance, endogenous amines such as tyramine and tryptamine, and represent potential targets for neuropsychiatric diseases. However, some members of this ... Read more...

[Narcolepsy and other hypersomnias]

6 Oct 2009 BACKGROUND: Narcolepsy is currently categorized into three groups; narcolepsy with and without emotionally triggered loss of muscle tone (cataplexy), and narcolepsy secondary to other medical conditions. Many patients with hypersomnia are diagnosed ... Read more...

Latest indexed articles for 'Central Nervous System Stimulants'

These are the very latest articles for this heading:

• Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation. 30 Oct 2009
• Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. 21 Oct 2009
• Disease mongering and excessive daytime sleepiness. 13 Oct 2009
• Age-related changes in motor subtle signs among girls and boys with ADHD. 11 Oct 2009
• [Narcolepsy and other hypersomnias] 6 Oct 2009
• Turbocharging the brain. 29 Sep 2009
• Amphetamine and environmentally induced hyperthermia differentially alter the expression of genes regulating vascular tone and angiogenesis in the meninges and associated vasculature. 29 Sep 2009
• 42-year-old male methamphetamine user with dysarthria and facial droop. 29 Sep 2009
• Similar neurons, opposite adaptations: psychostimulant experience differentially alters firing properties in accumbens core versus shell. 28 Sep 2009
• [Neuroenhancement: doping for the brain] 27 Sep 2009
• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009
• An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. 13 Sep 2009
• [Basic sleep mechanisms] 8 Sep 2009
• [The parent questionnaire "ADHD-knowledge and motivation for treatment" - development and first results] 30 Aug 2009
• [The assessment of Attention Deficit Hyperactivity Disorder (ADHD) by teacher ratings - validity and reliability of the FBB-HKS] 30 Aug 2009
• [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD] 30 Aug 2009
• Characterization of route specific impurities found in methamphetamine synthesized by the Leuckart and reductive amination methods. 30 Aug 2009
• Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices. 30 Aug 2009
• Armodafinil. 30 Aug 2009
• Stimulant medication use and response to growth hormone therapy: an NCGS database analysis. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Central Nervous System Stimulants'

Definition: A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Registry Number: 0

Descriptor UI: D000697

Alternative terms: Central Nervous System Stimulants; Central Stimulants; Stimulants, Central; Analeptics; Analeptic Drugs; Drugs, Analeptic; Analeptic Agents; Agents, Analeptic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.282; D27.505.954.427.220;

Online Note: use CENTRAL NERVOUS SYSTEM STIMULANTS to search ANALEPTICS 1966-94

History Note: 95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94

Technical Notes: GEN or unspecified; prefer specifics; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff; DF: CNS STIMULANTS